A Clinical Study of the Comfilcon A Asphere Soft Contact Lens in Users of Digital Devices
- Disease/Condition
- Ametropia
- Drug/Device/Intervention
- comfilcon A asphere
- Study type
- Interventional
- Intervention type
- device
- Primary sponsor
- Coopervision, Inc.
- Location
- Manchester, United Kingdom
- Phase
- N/A
- Start date
- Jul 04, 2019
- End date
- Mar 30, 2020
- Enrollment
- 61 participants
Symptom of Burning,Symptom of Burning,Symptom of Burning,Symptom of Itching,Symptom of Itching,Symptom of Itching,Symptom of Feeling of Foreign Body,Symptom of Feeling of Foreign Body,Symptom of Feeling of Foreign Body,Symptom of Tearing,Symptom of Tearing,Symptom of Tearing,Symptom of Excessive Blinking,Symptom of Excessive Blinking,Symptom of Excessive Blinking,Symptom of Eye Redness,Symptom of Eye Redness,Symptom of Eye Redness,Symptom of Eye Pain,Symptom of Eye Pain,Symptom of Eye Pain,Symptom of Heavy Eyelids,Symptom of Heavy Eyelids,Symptom of Heavy Eyelids,Symptom of Dryness,Symptom of Dryness,Symptom of Dryness,Symptom of Blurred Vision,Symptom of Blurred Vision,Symptom of Blurred Vision,Symptom of Double Vision,Symptom of Double Vision,Symptom of Double Vision,Symptom of Difficulty Focusing For Near Vision,Symptom of Difficulty Focusing For Near Vision,Symptom of Difficulty Focusing For Near Vision,Symptom of Increased Sensitivity to Light,Symptom of Increased Sensitivity to Light,Symptom of Increased Sensitivity to Light,Symptom of Colored Haloes Around Objects,Symptom of Colored Haloes Around Objects,Symptom of Colored Halos Around Objects,Symptom of Feeling That Sight is Worsening,Symptom of Feeling That Sight is Worsening,Symptom of Feeling That Sight is Worsening,Symptom of Headache,Symptom of Headache,Symptom of Headache
The aim of this work is to investigate the clinical performance and subjective acceptance of
 the comfilcon A asphere contact lens when compared to single-vision spectacles in subjects
 who have never worn contact lenses and who use digital devices (such as phones, tablets,
 laptops, desktop computers) for at least 4 hours per day on at least 5 days per week.
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT04067050
- Type
- Device Trial
Access comprehensive clinical trial information for NCT04067050 through Pure Global AI's free database. This phase not specified trial is sponsored by Coopervision, Inc. and is currently Completed. The study focuses on Ametropia. Target enrollment is 61 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.